Reduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia

Author： Weickert Cynthia Shannon Webster Maree J.

ISSN： 1460-2199

Source： Cerebral Cortex, Vol.11, Iss.2, 2001-02, pp. : 136-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients

By Kozlovsky N. Shanon-Weickert C. Tomaskovic-Crook E. Kleinman J. E. Belmaker R. H. Agam G.

Journal of Neural Transmission, Vol. 111, Iss. 12, 2004-12 ,pp. : 1583-1592

Springer Publishing Company

Access to resources Recommend Favorite

Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder

By Morris Harvey M. Hashimoto Takanori Lewis David A.

Cerebral Cortex, Vol. 18, Iss. 7, 2008-07 ,pp. : 1575-1587

Oxford University Press

Access to resources Recommend Favorite

Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia

By Farzan Faranak

Brain, Vol. 133, Iss. 5, 2010-05 ,pp. : 1505-1514

Oxford University Press

Access to resources Recommend Favorite

Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited

By Duyn J.

Cerebral Cortex, Vol. 10, Iss. 11, 2000-11 ,pp. : 1078-1092

Oxford University Press

Access to resources Recommend Favorite

[ 3 H]RX 821002 in human dorsolateral prefrontal cortex: no changes in postmortem tissue from subjects with schizophrenia

By Dean B.

Psychiatry Research, Vol. 119, Iss. 1, 2003-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite